Virtus LifeSci Biotech Products ETF
13 hedge funds and large institutions have $3.43M invested in Virtus LifeSci Biotech Products ETF in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.63% less ownership
Funds ownership: 17.96% → 17.33% (-0.63%)
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$486K | |
| 2 | +$365K | |
| 3 | +$221K | |
| 4 |
LPL Financial
San Diego,
California
|
+$14.5K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$9.55K |
Top Sellers
| 1 | -$524K | |
| 2 | -$163K | |
| 3 | -$26K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$17K |
| 5 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$11.6K |